Projects
About me
Gregor graduated with a Biomedical Engineering degree from The Technical University of Berlin and received his Master of Science (MSc) from the Max Plank Institute for Molecular Genetics in Berlin in 2004. He then moved to Ireland and attained a scholarship position at the Royal College of Surgeons in Ireland, obtaining his PhD in clinical cancer research in 2008 and after several years at the Biomedical Diagnostics Institute in Ireland, he took up his position at Mater in 2017.
Gregor is heading the Immune Profiling and Cancer Research Group at Mater Research. His research is concerned with humoral adaptive immune responses in cancer, a type of immune response involving the secretion of tumour-specific antibodies to the body fluids in response to cancer. By examining the antibody profile signatures of cancer patients and identifying those informing of disease progression and treatment; his research aims at identifying unique diagnostic and prognostic biological information (i.e. biomarkers) and might lead to the exploration of new targets for immunotherapy.
Publications
-
Referencing cross-reactivity of detection antibodies for protein array experiments
Lemass, Darragh, O'Kennedy, Richard and Kijanka, Gregor S. (2016) Referencing cross-reactivity of detection antibodies for protein array experiments. F1000Research, 5 73.1-73.15. doi:10.12688/f1000research.7668.2
-
Kijanka, Gregor S., Dimov, Ivan K., Burger, Robert and Ducrée, Jens (2015) Real-time monitoring of cell migration, phagocytosis and cell surface receptor dynamics using a novel, live-cell opto-microfluidic technique. Analytica Chimica Acta, 872 95-99. doi:10.1016/j.aca.2014.12.035
-
Fitzgerald, Sean, Sheehan, Katherine M., Espina, Virginia , O’Grady, Anthony, Cummins, Robert, Kenny, Dermot, Liotta, Lance, O’Kennedy, Richard, Kay, Elaine W. and Kijanka, Gregor S. (2015) High CerS5 expression levels associate with reduced patient survival and transition from apoptotic to autophagy signalling pathways in colorectal cancer. The Journal of Pathology Clinical Research, 1 1: 54-56. doi:10.1002/cjp2.5
-
Kijanka, G., Hector, S., Kay, E. W., Murray, F., Cummins, R., Murphy, D., MacCraith, B. D., Prehn, J. H. and Kenny, D. (2010) Human IgG antibody profiles differentiate between symptomatic patients with and without colorectal cancer. Gut, 59 1: 69-78. doi:10.1136/gut.2009.178574
